Clinical Trial Update: Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating CACICOL20 for improving corneal epithelial healing after corneal cross-linking in Keratoconus patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• CACICOL20

Snippet

Sponsor: Medical University of Vienna | Conditions: Keratoconus | Phase 4 | Status: COMPLETED